November 08, 2018
Sponsored by
Horizon Discovery

Defining the Performance Characteristics of New NGS Assays with Reference Standards


Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This webinar provides a practical approach to using reference standards to define the performance characteristics of new next-generation sequencing assays during validation.

In this webinar, Robyn Sussman and Ashkan Bigdeli from the Center for Personalized Diagnostics at the University of Pennsylvania discuss how they used reference standards as part of the validation workflow for their NGS assays.

In one case, they used standards with varying degrees of damage to validate a low-input assay that can accommodate highly compromised formalin-fixed, paraffin embedded tissues.

Sponsored by

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.